BCPC - Company ID 0000009326
The table below shows BALCHEM CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.04B | $953.68M | $922.44M | $942.36M | $799.02M | $703.64M |
| Cost of revenue | $666.53M | $617.48M | $620.38M | $661.91M | $555.85M | $479.75M |
| Gross profit | $370.63M | $336.21M | $302.06M | $280.45M | $243.17M | $223.90M |
| R&D | $18.51M | $16.79M | $15.05M | $12.19M | $13.52M | $10.33M |
BALCHEM CORP reported annual revenue of $1.04B for fiscal year 2025. That is up 8.8% from $953.68M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $553.20M (FY 2016) to $1.04B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $67.42M |
| $67.59M |
| $53.42M |
| $55.66M |
| $41.73M |
| $43.79M |
| Operating income | $209.33M | $182.91M | $159.19M | $145.19M | $127.50M | $111.15M |
| Income tax | $44.19M | $37.98M | $28.72M | $28.38M | $29.13M | $21.79M |
| Net income | $154.85M | $128.48M | $108.54M | $105.37M | $96.10M | $84.62M |
| EPS (diluted) | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 |